RedHill Biopharma Ltd.: The Strategic Expansion and Clinical Progress are in line with the Company’s plans. Stock Target Price Unchanged. jaimeuss_admin 6 בSeptember 2018 Research 0 Comments Continue Reading
Energix Renewable Energies Ltd.: The revenues in H1 2017 attest the implementation of plans and expected growth in cash flows from projects. Target Price Unchanged. jaimeuss_admin 6 בSeptember 2018 Research 0 Comments Continue Reading
Cellect Biotechnology Ltd.: Company’s clinical development on track; we expect positive interim results in the coming months. Target Price unchanged. jaimeuss_admin 30 בAugust 2018 Research 0 Comments Continue Reading
Brainsway Ltd.: Market Trends Drive Revenue Growth. An Opportunity for Increased Value based on the scenario of the Successful Execution of the New Business Model jaimeuss_admin 30 בAugust 2018 Research 0 Comments Continue Reading